Targeted Therapies and Immunotherapies in the Treatment of Esophageal Cancers

Esophageal cancer (EC) is among the most frequent and deadly cancers around the world. While esophageal adenocarcinoma (EAC) has one of the fastest-growing incidences amongst cancers in the US, it also has one of the lowest survival rates due to the limited effective treatment options. Fortunately,...

Descripción completa

Detalles Bibliográficos
Autores principales: Barsouk, Adam, Rawla, Prashanth, Hadjinicolaou, Andreas V., Aluru, John Sukumar, Barsouk, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836115/
https://www.ncbi.nlm.nih.gov/pubmed/31561465
http://dx.doi.org/10.3390/medsci7100100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836115/
https://www.ncbi.nlm.nih.gov/pubmed/31561465
http://dx.doi.org/10.3390/medsci7100100

Ejemplares similares